Table 1.
Main epidemiological and clinical data in 217 patients included in the study
| Patients n/N (%) | |
|---|---|
| Age, mean ± SD (range),years ≤ 59 years |
52.55 ± 18.20 (5–82) 124/217 (57.1) |
| Male sex | 133/217 (61.3) |
| Patients from rural areas | 148/217 (68.2) |
| Professional activity-agriculture/livestock | 31/217 (14.3) |
| Contact with animals | 60/217 (27.6) |
| Immigrants | 6/217 (2.8) |
| Comorbidity | 73/217 (33.6) |
| Asyntomatic/casual finding | 129/217 (59.4) |
| Clinical manifestations Mechanics Infectious Allergic |
88/217 (40.6) 54/88 (61.3) 35/88 (39.7) 14/88 (15.9) |
| Eosinophilia (>0.450 × 109 eosinophils/L) | 65/217 (29.9) |
| ELISA (>1/80) | 105/217 (48.4) |
| Cyst location (multiple response variable) | |
| Liver Lung Others/disseminated |
193/217 (88.9) 12/217 (5.5) 31/217 (14.2) |
| No. of cysts, mean ± SD (range) 1 ≥ 2 |
1.95 ± 2.66 (1–20) 137/217 (63.1) 80/217 (36.9) |
| Size of the largest cyst, mean ± SD (range),cm ≥ 7 cm ≤ 6.9 cm |
8.18 ± 4.35 (1–23) 122/217 (56.2) 95/217 (43.8) |
| WHO classification CE1 CE2 CE3 CE4 CE5 |
193/217 (88.9) 10/193 (5.2) 59/193 (30.6) 32/193 (16.6) 30/193 (15.5) 62/193 (32.1) |
| Treatment | |
| Combined treatment (Antihelminths & surgical) Surgical technics Surgical treatment complications |
141/217 (65.0) 76/217 (35.0) 38/217 (17.5) |
| Cohort mortality from all causes | 13/217 (6.0)a |
| Mortality attributable to hydatidosis | 2/217 (0.9)b |
aExitus ethiology: cardiovascular 1. Cancer 1. Infectious 5. No data 6
bExitus ethiology for E. granulosus: Infectious (sepsis) 1. Hemoptysis 1